Format

Send to

Choose Destination
See comment in PubMed Commons below
Br J Cancer. 1995 Jul;72(1):174-7.

Potential for cost economies in guiding therapy in patients with metastatic breast cancer.

Author information

1
Department of Surgery, City Hospital, Nottingham, UK.

Abstract

Therapeutic response in patients with advanced breast cancer is conventionally assessed with reference to criteria devised by the International Union Against Cancer. Evidence to date suggests, however, that assessments of equivalent quality may be obtained at lower cost from the use of serum markers. The paper presents estimates of potential cost savings resulting from the use of serum markers in place of conventional assessment and argues that the size of these savings merits the establishment of a randomised controlled trial.

PMID:
7599049
PMCID:
PMC2034118
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center